Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S.

Heartflow is once again looking for a path to go public, with a filing for a Nasdaq IPO. | The former Fierce Medtech Fierce ...

Heartflow has filed for an initial public offering. The company recorded sales of $125.8 million and a net loss of $96.4 million last year, according to a filing with the Securities and Exchange ...

The U.S. IPO market is witnessing a renewed vigor as investors return following months of sluggish activity triggered by ...

MIAX-parent Miami International Holdings on Friday reported a wider quarterly loss in its filing for a U.S. initial public ...

In a bold bid to electrify Wall Street and revolutionize how heart disease is diagnosed, Heartflow, a medical technology ...

Heartflow Inc. continued the steady rhythm of med-tech companies filing to go public, with an S-1 submitted to the U.S. SEC ...

The health landscape sees pivots as companies adjust strategies: Bristol Myers and Pfizer offer discounts on Eliquis, Newcastle University's IVF technique prevents genetic diseases, and Juul's ...

HDB IPO GMP, HDB Financial Services IPO Subscription: HDB Financial Services IPO fully subscribed within two days. Find out if this issue is a 'Subscribe' or 'Avoid'?

Hinge Health and Omada Health reawakened the digital health IPO market. But most late-stage healthcare startups aren't ready to follow them this year.

The 12,500-crore IPO of HDB Financial Services saw strong investor interest on Day 2, as the issue got fully subscribed on its second day of bidding (June 26).